ACCEL Lite: ESC Late-Breaker: DANCAVAS - Screening and Intervention to Prevent Cardiovascular Disease
In the DANCAVAS Trial, researchers found a remarkable reduction in death of any cause, and this might be a game changer in prevention of cardiovascular diseases.
In this interview, Axel Cosmus Pyndt Diederichsen MD and Clyde W. Yancy MD, MSc, MACC, FAHA, MACP, FHFSA, FASPC (Hon.) discuss ESC Late-Breaker: DANCAVAS: screening and intervention to prevent cardiovascular disease.
Clinical Topics: Prevention
Keywords: ACCELLite, ESC Congress, ESC22, Primary Prevention, Secondary Prevention
< Back to Listings